5 research outputs found
The Advocate - June 8, 1961
Original title (1951-1987)--The Advocate: official publication of the Archdiocese of Newark (N.J.)
Multisystemic Long-Term Sequelae of Covid-19: A Review Based on the Current Literature Over a Year of Pandemic Experience
On January 7, 2020, it was announced that the Chinese Government isolated a new variant of Coronavirus (SARS CoV-2). Officials reported that populations were not equally affected in terms of the number of cases, severe illness, and death. As of 28 December 2020, 81,000,000 cases have been confirmed globally, and approximately 1,770,000 total deaths have been reported for COVID-19. Besides difficulties of COVID-19 management in the acute stage, long-term consequences of the infection could cause widespread public health problems across the World. This review article aims to examine current literature regarding COVID-19, identify post-illness sequelae, detect patients at risk for sequelae, and provide guidance to management strategies. In the report, long-term pulmonary sequels and systemic problems including cardiovascular, neurological, psychiatric, endocrinologic, nephrological, hematologic, gastrointestinal, dermatologic, etc. of COVID-19 are discussed in accordance with recent scientific publications
Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey
WOS: 000468584300005PubMed ID: 30930455Objective: Heart failure (HF) has a high prevalence and mortality rate in elderly patients; however, there are few studies that have focused on patients older than 80 years. The aim of this study is to describe and compare the age-specific demographics and clinical features of Turkish elderly patients with HF who were admitted to cardiology clinics. Methods: The Epidemiology of Cardiovascular Disease in Elderly Turkish population (ELDER-TURK) study was conducted in 73 centers in Turkey, and it recruited a total of 5694 patients aged 65 years or older. In this study, the clinical profile of the patients who were aged 80 years or older and those between 65 and 79 years with HF were described and compared based on the ejection fraction (EF)-related classification: HFrEF and HFpEF (is considered as EF: >= 50%). Results: A total of 1098 patients (male, 47.5%; mean age, 83.5 +/- 3.1 years) aged 80 years and 4596 patients (male, 50.2 %; mean age, 71.1 +/- 4.31 years) aged 65-79 years were enrolled in this study. The prevalence of HF was 39.8% for patients who were >= 80 years and 27.1% for patients 65-79 years old. For patients aged >= 80 years with HF, the prevalence rate was 67% for hypertension (HT), 25.6% for diabetes mellitus (DM), 54.3% for coronary artery disease (CAD), and 42.3% for atrial fibrilation. Female proportion was lower in the HFrEF group (p=0.019). The prevalence of HT and DM was higher in the HFpEF group (p= 80 years with HFrEF (p<0.01). Conclusion: HF is common in elderly Turkish population, and its frequency increases significantly with age. Females, diabetics, and hypertensives are more likely to have HFpEF, whereas CAD patients are more likely to have HFrEF.Turkish Society of CardiologyThis study was supported by Turkish Society of Cardiology
Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey
Objective: Heart failure (HF) has a high prevalence and mortality rate
in elderly patients; however, there are few studies that have focused on
patients older than 80 years. The aim of this study is to describe and
compare the age-specific demographics and clinical features of Turkish
elderly patients with HF who were admitted to cardiology clinics.
Methods: The Epidemiology of Cardiovascular Disease in Elderly Turkish
population (ELDER-TURK) study was conducted in 73 centers in Turkey, and
it recruited a total of 5694 patients aged 65 years or older. In this
study, the clinical profile of the patients who were aged 80 years or
older and those between 65 and 79 years with HF were described and
compared based on the ejection fraction (EF)-related classification:
HFrEF and HFpEF (is considered as EF: >= 50\%).
Results: A total of 1098 patients (male, 47.5\%; mean age, 83.5 +/- 3.1
years) aged 80 years and 4596 patients (male, 50.2 \%; mean age, 71.1
+/- 4.31 years) aged 65-79 years were enrolled in this study. The
prevalence of HF was 39.8\% for patients who were >= 80 years and 27.1\%
for patients 65-79 years old. For patients aged >= 80 years with HF, the
prevalence rate was 67\% for hypertension (HT), 25.6\% for diabetes
mellitus (DM), 54.3\% for coronary artery disease (CAD), and 42.3\% for
atrial fibrilation. Female proportion was lower in the HFrEF group
(p=0.019). The prevalence of HT and DM was higher in the HFpEF group
(p<0.01), whereas CAD had a higher prevalence in the HFrEF group
(p=0.02). Among patients aged 65-79 years, 43.9\% (548) had HFpEF, and
56.1\% (700) had HFrEF. In this group of patients aged 65-79 years with
HFrEF, the prevalence of DM was significantly higher than in patients
aged >= 80 years with HFrEF (p<0.01).
Conclusion: HF is common in elderly Turkish population, and its
frequency increases significantly with age. Females, diabetics, and
hypertensives are more likely to have HFpEF, whereas CAD patients are
more likely to have HFrEF